| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0084 | 0.9 |